A61K 9/2022
Organic macromolecular compounds
Official title: {Organic macromolecular compounds}
A61K9/2022 (Organic macromolecular compounds) appears on 6,812 US grants and 12,476 published applications in this corpus.
Search patents in A61K- Granted patents
- 6,812
- Published applications
- 12,476
- Assignees
- 3,516
- Inventors
- 18,640
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 21 | 0 |
| 1977 | 10 | 0 |
| 1978 | 18 | 0 |
| 1979 | 13 | 0 |
| 1980 | 12 | 0 |
| 1981 | 17 | 0 |
| 1982 | 18 | 0 |
| 1983 | 18 | 0 |
| 1984 | 21 | 0 |
| 1985 | 25 | 0 |
| 1986 | 26 | 0 |
| 1987 | 31 | 0 |
| 1988 | 39 | 0 |
| 1989 | 61 | 0 |
| 1990 | 48 | 0 |
| 1991 | 57 | 0 |
| 1992 | 48 | 0 |
| 1993 | 43 | 0 |
| 1994 | 36 | 0 |
| 1995 | 55 | 0 |
| 1996 | 60 | 0 |
| 1997 | 85 | 0 |
| 1998 | 69 | 0 |
| 1999 | 100 | 0 |
| 2000 | 108 | 0 |
| 2001 | 162 | 63 |
| 2002 | 126 | 184 |
| 2003 | 142 | 354 |
| 2004 | 99 | 358 |
| 2005 | 83 | 374 |
| 2006 | 85 | 347 |
| 2007 | 64 | 375 |
| 2008 | 61 | 422 |
| 2009 | 63 | 376 |
| 2010 | 125 | 454 |
| 2011 | 144 | 442 |
| 2012 | 183 | 449 |
| 2013 | 268 | 550 |
| 2014 | 349 | 594 |
| 2015 | 349 | 635 |
| 2016 | 337 | 628 |
| 2017 | 400 | 628 |
| 2018 | 314 | 552 |
| 2019 | 323 | 577 |
| 2020 | 348 | 616 |
| 2021 | 352 | 604 |
| 2022 | 311 | 630 |
| 2023 | 271 | 603 |
| 2024 | 324 | 581 |
| 2025 | 294 | 586 |
| 2026 | 196 | 494 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Tableting of specific polymer stabilizers6 Oct 2026US 12,751,926 B2BASF SE
- Dosage forms for TYK2 inhibitors6 Oct 2026US 12,751,948 B2Bristol-Myers Squibb Company
- Formulation for oral administration, comprising triazine derivative6 Oct 2026US 12,751,955 B2Shionogi & Co., Ltd.
- Combination drug for the control and management of type 2 diabetes mellitus6 Oct 2026US 12,751,958 B2Laboratorios Silanes S.A. de C.V.
- Oral formulations and uses thereof29 Sep 2026US 12,746,229 B2Inventisbio Co., Ltd.
- Drug-polymer amorphous solid dispersions using linear polyacrylic acid polymers8 Oct 2026US 2026/0306410 A1Lubrizol Advanced Materials, Inc.
- Pharmaceutical oral dosage form of q2038 Oct 2026US 2026/0306411 A1Qurient Co., Ltd.
- Triptolide formulations8 Oct 2026US 2026/0306412 A1Minneamrita Therapeutics LLC
- Colonic purgative tablet and colonic purgative comprising same8 Oct 2026US 2026/0306413 A1Pharmbio Korea Co., Ltd.
- Compounds and combinations thereof for treating neurological and psychiatric conditions8 Oct 2026US 2026/0306426 A1Antecip Bioventures II LLC
Most cited
By later US patents
- Temperature-controlled active agent dispenser1,474US 4,830,855 ALandec Labs, Inc. · 1989
- Method of moving a delivery member of a dispensing device for administration of oral transmucosal dosage forms654US 8,499,966 B2AcelRx Pharmaceuticals, Inc. · 2013
- Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels548US 6,605,294 B2Incept, LLC · 2003
- Controlled release oxycodone compositions466US 5,508,042 AEuro-Celtigue, S.A. · 1996
- Biodegradable, implantable drug delivery depots, and method for preparing and using the same453US 4,450,150 AArthur D. Little, Inc. · 1984